GLP-1s and the Apparel Demand Reset: What We Heard at George Mason Center for Retail Transformation
- Apr 24
- 4 min read
Updated: 5 minutes ago
April 24th, 2026
Sizeo recently sponsored a panel at the George Mason Center for Retail Transformation, moderated by Gray King, on what GLP-1 medications are doing to apparel demand to size curves, to inventory risk, and to the way consumers are buying. The full video is below. This post is a recap for anyone short on time, plus a few of the moments I'm still thinking about.
I was joined by three people I've been wanting to hear from on this topic for a while:
Dr. Martin Binks, Professor and Chair of Nutrition and Food Studies at George Mason, and a metabolic disease scientist and clinician with 25+ years of work on weight loss and GLP-1 medications.
Jim Schwender, Managing Director at Accenture leading retail strategy, with prior executive tenure at Victoria's Secret and
across major apparel organizations.
Vanessa LeFebvre, currently President of GIII, formerly President of Champion, with leadership roles at TJX, Macy's, Stitch Fix, and Adidas.
A few takeaways stood out:
1. This is structural, not cyclical.
Jim drew the sharpest version of this distinction. Retailers are used to managing through cyclical shocks COVID, tariffs, geopolitical disruption. Those are temporary. GLP-1 adoption isn't.
"This isn't like a typical disruption, like COVID. This is structural it's not cyclical." — Jim Schwender
That distinction matters because the playbook is different. Cyclical disruption is something you ride out. Structural change is something you re-architect for.
2. The population is actually moving.
When we asked Martin whether GLP-1 adoption is showing up at the population level, not just in individual outcomes, he came back with a clear answer: yes. The data points to a measurable downward shift in population BMI, translating to roughly 15 pounds of weight loss for a typical patient on these medications.
And the trajectory isn't slowing. With oral semaglutide now approved, list prices coming down, and insurance coverage expanding into adjacent indications like cardiovascular health, sleep apnea, and kidney disease, Martin expects adoption to keep climbing rather than plateau.
We don't yet have a clean public dataset translating BMI movement into specific size curve shifts. But the directional signal is unambiguous.
3. The size curve isn't moving uniformly and that's the hard part.
The quote I'll keep coming back to from this panel came from Vanessa, when we were talking about who's actually showing up in retailers' size data right now:
"You have people moving in at the top of your size curve who quite frankly were never your customer before they're a new customer. You also have people who were an extra large who are a medium all of a sudden. And you also have people going the other way." — Vanessa LeFebvre
That's three cohorts moving in three different directions, all at once. Static, annually-refreshed size curves were already an awkward fit for a retail industry that's gotten faster everywhere else. They're a much worse fit now.
4. The opportunity is as big as the risk.
It would be easy to read this conversation as a margin-risk story and there's real markdown exposure for retailers who misread their size mix over the next 12 to 24 months. But Vanessa pushed us to think about the upside, and that's where the conversation got more interesting.
GLP-1 users aren't just losing weight. They're rebuilding their wardrobes. They're buying skincare. They're showing up in performance and athleisure. They're trying silhouettes and colors they wouldn't have considered before. Vanessa shared a personal example about her teenage son going from oversized sweats to slim-cut jeans and woven shirts after losing 40 pounds confidence-driven spend, in real time.
The macro data is consistent with that. Intimate apparel is growing at roughly 10% — nearly triple the broader retail rate. Denim is in a refresh cycle. Stitch Fix has launched a dedicated GLP-1 stylist program. The retailers paying close attention are finding revenue, not just defending margin.
5. What to do about it.
Jim closed with three things he'd tell any retail leader to focus on right now:
Build size mobility into planning up front. Not just size scales silhouette and cut.
Lean on demand sensing over historical baselines. The past doesn't predict the present cleanly here.
Push supply chain responsiveness. Make the size and silhouette commitments as late in the cycle as you possibly can.
His own framing of the underlying problem was sharp. A lot of retail organizations are still running on a "set my size scale once a year" cadence. That was already overdue for an update. Now it's a real liability.
Vanessa added a customer-experience point that I think gets underweighted in the operational discussion: customer patience is finite. If a customer comes into your store after a body composition change and can't find her size or the silhouettes she's looking for, she isn't giving you many more chances. The cost of a mismatched size mix isn't only the markdown, it's the customer you don't see again.
What's next.
This was deliberately the first conversation, not the last. The center has a research agenda forming around GLP-1s and apparel demand, and we'll be running additional sessions over the coming months.
If you're working through this inside your own organization and want to compare notes, reach out. The best way to get smarter on this is to talk to the people in the seats making the decisions.
Comments